Total assets · 2015–2025

AstraZeneca total assets

$114B+9.6% · FY2025

AstraZeneca (AZN) reported $114B in total assets for fiscal 2025, +9.6% year on year.

$60.1B2015$62.5B2016$63.4B2017$60.7B2018$61.4B2019$66.7B2020$105B2021$96.5B2022$101B2023$104B2024$114B2025
AstraZeneca — Total assets, 2015–2025
Fiscal yearTotal assetsChangeFiling
FY20252025-12-31$114B+9.6%Open →
FY20242024-12-31$104B+2.9%Open →
FY20232023-12-31$101B+4.8%Open →
FY20222022-12-31$96.5B−8.4%Open →
FY20212021-12-31$105B+57.9%Open →
FY20202020-12-31$66.7B+8.7%Open →
FY20192019-12-31$61.4B+1.2%Open →
FY20182018-12-31$60.7B−4.3%Open →
FY20172017-12-31$63.4B+1.3%Open →
FY20162016-12-31$62.5B+4.1%Open →
FY20152015-12-31$60.1B—Open →

Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +6.6%

Figures are reported under IFRS, in US dollars.

Total assets at companies of similar size

Full ranking by total assets →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=AstraZeneca total assets |url=https://companiesranked.com/en/company/astrazeneca/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). AstraZeneca total assets. CompaniesRanked. https://companiesranked.com/en/company/astrazeneca/total-assets

BibTeX

@misc{companiesranked-en-company-astrazeneca-total-assets-2026,
  author       = {{CompaniesRanked}},
  title        = {{AstraZeneca total assets}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/astrazeneca/total-assets}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001104659-26-019130 · February 24, 2026

{{cite web |title=AstraZeneca total assets — 20-F (0001104659-26-019130) |url=https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/azn-20251231x20f.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← AstraZeneca overview